Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds QIAGEN Highlights Launch

FDA
News

QIAGEN Highlights Launch

https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2022/QIAGEN-launches-new-solutions-that-significantly-accelerate-DNA-variant-detection-and-RNA-sequencing-of-low-input-samples/default.as

byBenzinga Newsdesk

August 9, 2022

1 minute read

USANA Health Sciences Shares Plunge On Q2 Preliminary Results, FY22 Guidance Cut

By Akanksha Bakshi

July 6, 5:20 PM

USANA Health Sciences, Inc. (NYSE:USNA) shares slid in the post-market session after it reported preliminary second-quarter results and updated its…

USNA

NeuroSense Therapeutics Files For Mixed-Securities Shelf Offering Of Up To $100M

By Michael Horton

January 19, 6:25 PM

-SEC Filing

NRSN

Morgan Stanley Maintains Underweight on NeuroPace, Lowers Price Target to $2.5

By Benzinga Newsdesk

January 6, 11:02 AM

Morgan Stanley analyst Drew Ranieri maintains NeuroPace (NASDAQ:NPCE) with a Underweight and lowers the price target from $3.5 to $2.5.

NPCE

Mullen Automotive Secures Major European Order for Delivery EVs

By Anusuya Lahiri

May 29, 12:30 PM

Mullen Automotive, Inc (NASDAQ: MULN) received a $440,000 purchase order from Antidoto SA for 40 Mullen-GO electric delivery vehicles, with plans for future expansion in Europe.

CCSO

QIAGEN Highlights Launch

Related Posts

USANA Health Sciences Shares Plunge On Q2 Preliminary Results, FY22 Guidance Cut

NeuroSense Therapeutics Files For Mixed-Securities Shelf Offering Of Up To $100M

Morgan Stanley Maintains Underweight on NeuroPace, Lowers Price Target to $2.5

Mullen Automotive Secures Major European Order for Delivery EVs